research use only
Cat.No.S7718
| Related Targets | HDAC PARP ATM/ATR DNA-PK WRN Topoisomerase PPAR Sirtuin Casein Kinase eIF |
|---|---|
| Other DNA/RNA Synthesis Inhibitors | CX-5461 (Pidnarulex) B02 SCR7 Favipiravir (T-705) EED226 RK-33 Triapine (3-AP) Carmofur YK-4-279 Halofuginone |
|
In vitro |
DMSO
: 2 mg/mL
(5.54 mM)
Warmed with 50°C water bath;
Ultrasonicated;
Ethanol : 2 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 360.41 | Formula | C21H20N4O2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 896705-16-1 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CN(C)CCNC(=O)C1=CC=CN2C1=NC3=CC4=CC=CC=C4C=C3C2=O | ||
| Targets/IC50/Ki |
RNA polymerase I
|
|---|---|
| In vitro |
BMH-21 causes proteasome-dependent destruction of RPA194, the large catalytic subunit protein of Pol I holocomplex. In U2OS cancer cell line, this compound results in degradation of RPA194 and translocation of NCL with IC50 of 0.05 μM and 0.07 μM, respectively. By causing nucleolar stress, it also shows potent inhibition on cell viability. |
| In vivo |
This compound reduces tumor growth in mouse xenografts. |
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | MDM2 / p53 / p-p53 Bax / Caspase-3 / Cleaved caspase-3 |
|
28656213 |
| Growth inhibition assay | Cell viability |
|
28656213 |
| Immunofluorescence | Nuclephosmin Fibrillarin |
|
28656213 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.